Z-0500-2020 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0500-2020 was initiated by Becton Dickinson & Company on Oct 14, 2019 and is designated Class II. Reason for recall: Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes. The recall status is terminated (terminated Oct 16, 2020). Affected quantity: 967,680.

Recall details

Product Type
Devices
Report Date
Nov 27, 2019
Initiation Date
Oct 14, 2019
Termination Date
Oct 16, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
967,680

Product description

BD Posiflush Pre-Filled Normal Saline Syringes Catalog Number: 306575 (Canada only)

Reason for recall

Limited number of syringes labeled Posiflush Experimental Product and Not for Human Use being mixed with standard BD Posiflush Pre-Filled Normal Saline Syringes.

Distribution pattern

Distribution US Nationwide and Canada

Code information

Lot Number: 9175971 UDI: 50382903065757

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0500-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0500-2020. Report a data issue: hello@regdatalab.com.